Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1995 May;221(5):446–458. doi: 10.1097/00000658-199505000-00002

Progress in renal transplantation. A single center study of 3359 patients over 25 years.

A G Diethelm 1, M H Deierhoi 1, S L Hudson 1, D A Laskow 1, B A Julian 1, R S Gaston 1, J S Bynon 1, J J Curtis 1
PMCID: PMC1234616  PMID: 7748026

Abstract

OBJECTIVE: The study analyzed 3359 consecutive renal transplant operations for patient and graft survival, including living related, cadaveric, and living unrelated patients. The analysis was separated into three groups according to immunosuppression and date of transplant. SUMMARY BACKGROUND DATA: Improvements in renal transplantation in the past 25 years have been the result of better immunosuppression, organ preservation, and patient selection. METHODS: A single transplant center's experience over a 25-year period was analyzed regarding patient and graft survival. Potential risk factors included patient demographics, tissue typing, donor characteristics, number of transplants, acute and chronic rejection, acute tubular necrosis, primary disease, and malignancy. RESULTS: The primary cause of graft loss was rejection. Improvement in cadaveric graft survival since 1987 with quadruple therapy was not apparent in living donor patients. Race continued to be a negative factor in graft survival. Avoiding previous mismatched antigens and the use of flow cytometry improved allograft survival. The leading cause of death in the past 7 years in cadaveric recipients was cardiac (52%). CONCLUSIONS: Improved graft survival in the past 25 years was related to 1) advances in immunosuppression, 2) better methods of cytotoxic antibody detection, and 3) human lymphocyte antigen match.

Full text

PDF
446

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barber W. H., Diethelm A. G., Laskow D. A., Deierhoi M. H., Julian B. A., Curtis J. J. Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients. Transplantation. 1989 Jan;47(1):66–71. doi: 10.1097/00007890-198901000-00015. [DOI] [PubMed] [Google Scholar]
  2. Barber W. H. Donor-specific transfusions in renal transplantation. Clin Transplant. 1994 Apr;8(2 Pt 2):204–206. [PubMed] [Google Scholar]
  3. Barber W. H., Laskow D. A., Deierhoi M. H., Poplawski S. C., Diethelm A. G. Comparison of simple hypothermic storage, pulsatile perfusion with Belzer's gluconate-albumin solution, and pulsatile perfusion with UW solution for renal allograft preservation. Transplant Proc. 1991 Oct;23(5):2394–2395. [PubMed] [Google Scholar]
  4. Barber W. H., Mankin J. A., Laskow D. A., Deierhoi M. H., Julian B. A., Curtis J. J., Diethelm A. G. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation. 1991 Jan;51(1):70–75. doi: 10.1097/00007890-199101000-00011. [DOI] [PubMed] [Google Scholar]
  5. Calne R. Y., White D. J., Thiru S., Evans D. B., McMaster P., Dunn D. C., Craddock G. N., Pentlow B. D., Rolles K. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet. 1978 Dec 23;2(8104-5):1323–1327. doi: 10.1016/s0140-6736(78)91970-0. [DOI] [PubMed] [Google Scholar]
  6. Cicciarelli J., Helstab K., Mendez R. Flow cytometry PRA, a new test that is highly correlated with graft survival. Clin Transplant. 1992 Jun;6(3 Pt 1):159–164. [PubMed] [Google Scholar]
  7. Collins G. M., Bravo-Shugarman M., Terasaki P. I. Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet. 1969 Dec 6;2(7632):1219–1222. doi: 10.1016/s0140-6736(69)90753-3. [DOI] [PubMed] [Google Scholar]
  8. Deierhoi M. H., Kauffman R. S., Hudson S. L., Barber W. H., Curtis J. J., Julian B. A., Gaston R. S., Laskow D. A., Diethelm A. G. Experience with mycophenolate mofetil (RS61443) in renal transplantation at a single center. Ann Surg. 1993 May;217(5):476–484. doi: 10.1097/00000658-199305010-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Deierhoi M. H., Sollinger H. W., Diethelm A. G., Belzer F. O., Kauffman R. S. One-year follow-up results of a phase I trial of mycophenolate mofetil (RS61443) in cadaveric renal transplantation. Transplant Proc. 1993 Feb;25(1 Pt 1):693–694. [PubMed] [Google Scholar]
  10. Diethelm A. G., Laskow D. A., Hudson S. L., Deierhoi M. H., Barber W. H., Barger B. O., Julian B. A., Gaston R. S., Curtis J. J. Benefits of quadruple immunosuppressive therapy in recipients of living related donor kidneys. A review of 855 operations. Ann Surg. 1992 Jun;215(6):606–617. doi: 10.1097/00000658-199206000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fontes P., Rao A. S., Demetris A. J., Zeevi A., Trucco M., Carroll P., Rybka W., Rudert W. A., Ricordi C., Dodson F. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet. 1994 Jul 16;344(8916):151–155. doi: 10.1016/s0140-6736(94)92756-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gaston R. S., Hudson S. L., Deierhoi M. H., Barber W. H., Laskow D. A., Julian B. A., Curtis J. J., Barger B. O., Shroyer T. W., Diethelm A. G. Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression. Transplantation. 1992 Jan;53(1):103–109. doi: 10.1097/00007890-199201000-00020. [DOI] [PubMed] [Google Scholar]
  13. Gaston R. S., Shroyer T. W., Hudson S. L., Deierhoi M. H., Laskow D. A., Barber W. H., Julian B. A., Curtis J. J., Barger B. O., Diethelm A. G. Renal retransplantation: the role of race, quadruple immunosuppression, and the flow cytometry cross-match. Transplantation. 1994 Jan;57(1):47–54. [PubMed] [Google Scholar]
  14. Häyry P., Isoniemi H., Yilmaz S., Mennander A., Lemström K., Räisänen-Sokolowski A., Koskinen P., Ustinov J., Lautenschlager I., Taskinen E. Chronic allograft rejection. Immunol Rev. 1993 Aug;134:33–81. doi: 10.1111/j.1600-065x.1993.tb00639.x. [DOI] [PubMed] [Google Scholar]
  15. Kaufman D. B., Matas A. J., Arrazola L., Gillingham K. J., Sutherland D. E., Payne W. D., Dunn D. L., Gores P. F., Najarian J. S. Transplantation of kidneys from zero haplotype-matched living donors and from distantly related and unrelated donors in the cyclosporine era. Transplant Proc. 1993 Feb;25(1 Pt 2):1530–1531. [PubMed] [Google Scholar]
  16. Kerman R. H., Kimball P. M., Lindholm A., Van Buren C. T., Katz S. M., Lewis R. M., McClain J., Podbielski J., Williams J., Kahan B. D. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival. Transplantation. 1993 Nov;56(5):1242–1247. doi: 10.1097/00007890-199311000-00037. [DOI] [PubMed] [Google Scholar]
  17. Knechtle S. J., Pirsch J. D., D'Alessandro A. M., Sollinger H. W., Kalayoglu M., Belzer F. O. Renal transplantation at the University of Wisconsin in the cyclosporine era. Clin Transpl. 1993:211–218. [PubMed] [Google Scholar]
  18. Laskow D. A., Deierhoi M. H., Hudson S. L., Orr C. L., Curtis J. J., Diethelm A. G. The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil (RS61443). Transplantation. 1994 Feb 27;57(4):640–643. [PubMed] [Google Scholar]
  19. MERRILL J. P., MURRAY J. E., HARRISON J. H., GUILD W. R. Successful homotransplantation of the human kidney between identical twins. J Am Med Assoc. 1956 Jan 28;160(4):277–282. doi: 10.1001/jama.1956.02960390027008. [DOI] [PubMed] [Google Scholar]
  20. Matas A. Chronic rejection in renal transplant recipients--risk factors and correlates. Clin Transplant. 1994 Jun;8(3 Pt 2):332–335. [PubMed] [Google Scholar]
  21. McDaniel D. O., Naftilan J., Hulvey K., Shaneyfelt S., Lemons J. A., Lagoo-Deenadayalan S., Hudson S., Diethelm A. G., Barber W. H. Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow. Transplantation. 1994 Mar 27;57(6):852–856. doi: 10.1097/00007890-199403270-00014. [DOI] [PubMed] [Google Scholar]
  22. Ploeg R. J., Pirsch J. D., Stegall M. D., Armbrust M. J., Lorentzen D. F., D'Alessandro A. M., Knechtle S. J., Sollinger H. W., Kalayoglu M., Belzer F. O. Living unrelated kidney donation: an underutilized resource? Transplant Proc. 1993 Feb;25(1 Pt 2):1532–1534. [PubMed] [Google Scholar]
  23. Sollinger H. W., Belzer F. O., Deierhoi M. H., Diethelm A. G., Gonwa T. A., Kauffman R. S., Klintmalm G. B., McDiarmid S. V., Roberts J., Rosenthal J. T. RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection. Ann Surg. 1992 Oct;216(4):513–519. doi: 10.1097/00000658-199210000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sollinger H. W., Deierhoi M. H., Belzer F. O., Diethelm A. G., Kauffman R. S. RS-61443--a phase I clinical trial and pilot rescue study. Transplantation. 1992 Feb;53(2):428–432. doi: 10.1097/00007890-199202010-00031. [DOI] [PubMed] [Google Scholar]
  25. Spital A. Unrelated living kidney donors. An update of attitudes and use among U.S. transplant centers. Transplantation. 1994 Jun 27;57(12):1722–1726. [PubMed] [Google Scholar]
  26. Starzl T. E., Demetris A. J., Murase N., Ildstad S., Ricordi C., Trucco M. Cell migration, chimerism, and graft acceptance. Lancet. 1992 Jun 27;339(8809):1579–1582. doi: 10.1016/0140-6736(92)91840-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Starzl T. E., Demetris A. J., Trucco M., Ramos H., Zeevi A., Rudert W. A., Kocova M., Ricordi C., Ildstad S., Murase N. Systemic chimerism in human female recipients of male livers. Lancet. 1992 Oct 10;340(8824):876–877. doi: 10.1016/0140-6736(92)93286-v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Starzl T. E., Weil R., 3rd, Iwatsuki S., Klintmalm G., Schröter G. P., Koep L. J., Iwaki Y., Terasaki P. I., Porter K. A. The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet. 1980 Jul;151(1):17–26. [PMC free article] [PubMed] [Google Scholar]
  29. Taylor C. J., Welsh K. I., Gray C. M., Bunce M., Bayne A. M., Sutton P. M., Gray D. W., Ting A., Morris P. J. Clinical and socioeconomic benefits of serological HLA-DR matching for renal transplantation over three eras of immunosuppression regimens at a single unit. Clin Transpl. 1993:233–241. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES